3 of Wall Street’s Favorite Stocks to Consider Right Now – StockStory

June 22, 2026
The stocks in this article have caught Wall Street’s attention in a big way, with price targets implying returns above 20%. But investors should take these forecasts with a grain of salt because analysts typically say nice things about companies so their firms can win business in other product lines like M&A advisory.
At StockStory, we look beyond the headlines with our independent analysis to determine whether these bullish calls are justified. That said, here are three stocks where Wall Street’s excitement appears well-founded.
Consensus Price Target: $548.69 (21.1% implied return)
Founded in 1989 with a mission to create medicines that treat the underlying causes of disease rather than just symptoms, Vertex Pharmaceuticals (NASDAQ:VRTX) develops and markets transformative medicines for serious diseases, with a focus on cystic fibrosis, sickle cell disease, and pain management.
Why Are We Fans of VRTX?
At $452.99 per share, Vertex Pharmaceuticals trades at 23.1x forward P/E. Is now the time to initiate a position? Find out in our full research report, it’s free.
Consensus Price Target: $387.23 (25.6% implied return)
With over 150 million patients impacted annually through its innovative healthcare technologies, Stryker (NYSE:SYK) develops and manufactures advanced medical devices and equipment across orthopedics, surgical tools, neurotechnology, and patient care solutions.
Why Are We Positive on SYK?
Stryker’s stock price of $308.42 implies a valuation ratio of 19.7x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.
Consensus Price Target: $107.50 (31% implied return)
Formerly known as Meta Financial until its 2022 rebranding, Pathward Financial (NASDAQ:CASH) provides banking-as-a-service solutions and commercial finance products, enabling partners to offer financial services like prepaid cards, payment processing, and lending options.
Why Do We Love CASH?
Pathward Financial is trading at $82.05 per share, or 2x forward P/B. Is now the time to initiate a position? Find out in our full research report, it’s free.
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it’s flagging this month — FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
©2026 StockStory
Data sources: actuals and consensus estimates from StockStory, S&P Global Market Intelligence, and Visible Alpha. Market data from Massive.
Provided for general information purposes only and does not constitute investment advice or a recommendation that any particular security, portfolio of securities, transaction or investment strategy is suitable for any specific individual. Information on our investment framework and performance methodology is available here.
Copyright 2026, S&P Global Market Intelligence (and its affiliates as applicable). All rights reserved.

source